Abstract
Recent data might subtly recalibrate the risk/benefit ratio of lithium, the prototypical mood stabiliser for bipolar disorder. There are hints that lithium might be associated with a reduction in dementia risk and as noted in this Journal, a surprising reduction in the risk of cancer.
Cite
CITATION STYLE
APA
Berk, M., Cowdery, S., Williams, L., & Malhi, G. S. (2017, July 1). Recalibrating the risks and benefits of lithium therapy. British Journal of Psychiatry. Royal College of Psychiatrists. https://doi.org/10.1192/bjp.bp.116.193789
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free